We describe a patient with chronic myeloid myeloid leukemia (CML) on tow-dose treatment with interferon (IFN) who developed systemic sarcoidosis, a rare IFN-related side effect, while in complete cytogenetic remission. We chose to continue IFN and to treat the sarcoidosis with prednisone. After eight months, the CML is still in complete cytogenetic remission and the sarcoidosis is almost completely resolved.

Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia / C., Fiorani; Sacchi, Stefano; G., Bonacorsi; Cosenza, Maria. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 85:(2000), pp. 1006-1007.

Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia

SACCHI, Stefano;COSENZA, Maria
2000

Abstract

We describe a patient with chronic myeloid myeloid leukemia (CML) on tow-dose treatment with interferon (IFN) who developed systemic sarcoidosis, a rare IFN-related side effect, while in complete cytogenetic remission. We chose to continue IFN and to treat the sarcoidosis with prednisone. After eight months, the CML is still in complete cytogenetic remission and the sarcoidosis is almost completely resolved.
85
1006
1007
Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia / C., Fiorani; Sacchi, Stefano; G., Bonacorsi; Cosenza, Maria. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 85:(2000), pp. 1006-1007.
C., Fiorani; Sacchi, Stefano; G., Bonacorsi; Cosenza, Maria
File in questo prodotto:
File Dimensione Formato  
1006.full.pdf

accesso aperto

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 92.1 kB
Formato Adobe PDF
92.1 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/310409
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 30
social impact